文献速递类风湿关节炎脊柱关节炎

类风湿关节炎与银屑病关节炎临床及超声缓解期滑膜特征差异

Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?
PubMed 文献 · Ann Rheum Dis · 2017-01-24

本研究对MTX联合TNF抑制剂治疗后达到临床和超声缓解的RA和PsA患者进行滑膜活检,发现超声阴性的RA缓解期患者滑膜组织学特征与低疾病活动度RA患者相似,而超声阴性的PsA缓解期患者仍存在残留滑膜炎症,表现为衬里下CD68+和CD3+细胞及CD31+血管评分更高。

要点

  • 超声阴性的RA缓解期患者滑膜组织学特征与低疾病活动度RA患者无显著差异。
  • 超声阴性的PsA缓解期患者较RA缓解期患者有更高的衬里下CD68+、CD3+细胞及CD31+血管评分。
  • PsA临床缓解后残留滑膜炎症可能解释其更高的复发风险。

核心结论

  • 超声阴性的RA缓解期患者滑膜组织学特征与低疾病活动度RA患者相当,而超声阴性的PsA缓解期患者仍存在较RA缓解期患者更明显的残留滑膜炎症。

研究设计与样本

  • 研究纳入接受MTX联合阿达木单抗40 mg或依那西普50 mg治疗且超声阴性(PDUS阴性)的RA缓解期患者25例、RA低疾病活动度患者10例和PsA缓解期患者18例,并进行滑膜组织活检,以50例未治疗的高/中度疾病活动度RA患者作为对照。

主要发现

  • 超声阴性的RA缓解期患者较超声阳性的高/中度疾病活动度RA患者,滑膜CD68+、CD20+、CD3+细胞、CD31+血管及胶原沉积的组织学评分均更低(p<0.05,衬里和衬里下均显著)。
  • 超声阴性的RA缓解期患者与超声阴性的RA低疾病活动度患者在衬里和衬里下CD68+、CD20+、CD3+、CD31+细胞及胶原方面均无显著差异。
  • 超声阴性的PsA缓解期患者较超声阴性的RA缓解期患者,衬里下CD68+细胞(p=0.02)、CD3+细胞(p=0.04)及CD31+血管(p<0.001)的组织学评分更高。

临床怎么用

  • 对于接受TNF抑制剂治疗的RA和PsA患者,即使达到临床和超声缓解,仍应认识到PsA可能存在残留滑膜炎症,需关注其复发风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To define the synovial characteristics of patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA) in clinical and ultrasound remission achieved by combination therapy with methotrexate (MTX) and tumour necrosis factor (TNF) blockers. METHODS: Patients with RA in remission (n=25) (disease activity score (DAS)<1.6 for at least 6 months), patients with RA in low disease activity (LDA) (n=10) (1.6<DAS<2.4 for at least 6 months) and patients with PsA in remission (n=18) (DAS<1.6 and Psoriasis Area Severity Index (PASI)=0 for at least 6 months) achieved by MTX+anti-TNF (adalimumab 40 mg or etanercept 50 mg) with power Doppler (PDUS)-negative synovial hypertrophy underwent synovial tissue biopsy. Patients with RA with high/moderate disease naïve to treatment (n=50) were included as a comparison group. Immunostaining for cluster designation (CD)68, CD21, CD20, CD3, CD31 and collagen was performed. RESULTS: PDUS-negative patients with RA in remission showed lower histological scores for synovial CD68+, CD20+, CD3+ cells and CD31+ vessels and collagen deposition (p<0.05 for both lining and sublining) compared with PDUS-positive patients with RA with high/moderate disease. In addition, there was no significant difference in terms of lining and sublining CD68+, CD20+, CD3+, CD31+ cells and collagen comparing PDUS-negative patients with RA in remission and in LDA, respectively. On the contrary, PDUS-negative patients with PsA in remission showed higher histological scores for sublining CD68+ (p=0.02) and CD3+ cells (p=0.04) as well as CD31+ vessels (p<0.001) than PDUS-negative patients with RA in remission. CONCLUSIONS: PDUS-negative patients with RA in remission have comparable synovial histological features than PDUS-negative patients with RA in LDA. However, patients with PsA in remission are characterised by a higher degree of residual synovial inflammation than patients with RA in remission, despite PDUS negativity under TNF inhibition.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Alivernini S, Tolusso B, Petricca L, et al. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission? Ann Rheum Dis. 2017. PMID: 28119289. doi:10.1136/annrheumdis-2016-210424

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。